Due to their substantial size, longitudinal integrity, and unique data links, the MarketScan® Research Databases  are the foundation of our data resources and research expertise for pharmacoepidemiology studies. These powerful data sets offer epidemiologists credible, real-world data for studies on disease history, incidence and prevalence, the clinical course of treatment, and provide context around adverse events.

Benefits

  • Superior database size supports studies on smaller populations
  • Exceptional retention rates include patients followed for up to a decade
  • Data captures the complete continuum of care: inpatient, outpatient, ambulatory, patient-reported lifestyle and biometrics, lab, and health and productivity
  • Data credibility is substantiated by a strong epidemiology publication record
  • Our researchers have extensive experience working with data for observational studies
  • Specialized data from electronic medical records, patient registries, and drug safety databases are available for oncology, cardiovascular, respiratory, and pharmacovigilence studies